David A. Bellnier

Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rate.

Barbara W. Henderson, Theresa M. Busch, Lurine A. Vaughan et al. · PubMed · 2000 · 249 citations

Optogenetics, Photofrin Photodynamic Therapy, Photochemistry +15

DISTRIBUTION AND ELIMINATION OF PHOTOFRIN II IN MICE

David A. Bellnier, Yau‐Kwan Ho, Ravindra K. Pandey et al. · Photochemistry and Photobiology · 1989 · 201 citations

Oxidative Stress, Skeletal Muscle, Phototoxicity +16

An in vivo quantitative structure-activity relationship for a congeneric series of pyropheophorbide derivatives as photosensitizers for photodynamic therapy.

Barbara W. Henderson, David A. Bellnier, William R. Greco et al. · PubMed · 1997 · 197 citations

Medicinal Chemistry, Pyropheophorbide Derivatives, Biochemistry +15

Synthesis, Photophysical Properties, Tumor Uptake, and Preliminary in Vivo Photosensitizing Efficacy of a Homologous Series of 3-(1‘-Alkyloxy)ethyl-3-devinylpurpurin-18-<i>N</i>-alkylimides with Variable Lipophilicity

Gang Zheng, William R. Potter, Susan H. Camacho et al. · Journal of Medicinal Chemistry · 2001 · 190 citations

Photodynamic therapy: a means to enhanced drug delivery to tumors.

John W. Snyder, William R. Greco, David A. Bellnier et al. · PubMed · 2003 · 177 citations

Nanomedicine, Photochemistry, Polymer-drug Conjugate +15